Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

In today's digital age, <keyword id="20114750" type="General" weightage="20" keywordseo="screen-time" source="keywords">screen time</keyword> is an integral part of life for people of all ages. However, recent preliminary research published in JAMA Network Open raises concerns about the impact of touch-screen <keyword id="22616884" type="General" weightage="20" keywordseo="tablet-games" source="keywords">tablet games</keyword> on <keyword id="20092400" type="General" weightage="20" keywordseo="toddlers" source="keywords">toddlers</keyword>, suggesting that frequent use may inhibit crucial interactions with their parents! The study highlights that early screen time is associated with delays in communication and problem-solving skills among toddlers. This aligns with a growing concern among parents regarding <keyword id="20083225" type="General" weightage="20" keywordseo="childrens-health" source="keywords">children's health</keyword>, with screen time topping recent polls as a significant issue. <div type="Article" hostid="261" msid="112016000" title="I run a preschool and see how gentle parenting has made parents less engaged with their kids. It&amp;#39;s time to ditch parenting scripts." mstype="2" mssubtype="0"></div>Dimitri A. Christakis, MD, MPH, director of the Center for Child Health, Behavior, and Development at Seattle Children's Research Institute, emphasised the importance of understanding <keyword id="21062651" type="General" weightage="20" keywordseo="digital-addiction" source="keywords">digital addiction</keyword>'s roots. “Compulsive use of screens appears to start in toddlerhood,” Christakis stated, highlighting a gap in current research focused on such young children. The researchers recruited 63 neurotypical toddlers aged 18 to 32 months to observe how they interacted with various stimuli and responded to attention bids from adults. The study involved providing toddlers with a farm toy, a tablet showing a child playing with the farm toy, a tablet with a farm-themed puzzle, a tablet with a farm-themed game, and a tablet with their favourite app. After one minute of exposure to each item, researchers and caregivers alternated attempts to capture the toddlers' attention. At the end, the researcher asked for the toy or tablet back. <h2>Evils of high screen time in children</h2>The findings revealed that toddlers were less responsive to prompts while playing the farm-themed game, which involved activities like shearing sheep. This effect was more pronounced as the children aged, and it was particularly significant among male toddlers, who took longer than female toddlers to acknowledge requests for behaviour changes. Additionally, toddlers with higher media usage at home were more likely to ignore prompts during the study. The study offers insights into the underlying mechanisms of delayed <keyword id="20607306" type="General" weightage="20" keywordseo="language-development" source="keywords">language development</keyword> linked to early screen use. Christakis explained, “early screen use deprives toddlers of opportunities to reciprocally engage with caregivers, which is a critical way children learn language and social skills.” The lack of joint attention during play with traditional toys, which is associated with better language skills, underscores the importance of human back-and-forth interaction for cognitive and social development. <div type="Article" hostid="261" msid="111816796" title="I&amp;#39;m a teacher and a parent. I support banning cellphones in classrooms." mstype="2" mssubtype="0"></div>While the study is preliminary, it sheds light on the need for further research to identify high-risk children and develop interventions promoting healthy screen use in early childhood. Christakis advocates for more comprehensive studies to understand better and mitigate the impact of screen time on young children's development. In conclusion, while touch-screen tablet games offer convenience and entertainment, their use should be balanced with traditional play and <keyword id="22616885" type="General" weightage="20" keywordseo="parent-child-interactions" source="keywords">parent-child interactions</keyword> to support <keyword id="22616886" type="General" weightage="20" keywordseo="healthy-development" source="keywords">healthy development</keyword> in toddlers. As research continues to evolve, it is crucial for parents and caregivers to stay informed and mindful of the potential long-term effects of early screen exposure.

“iPad kids” are less inclined to interact with their parents and show delays in problem-solving: Study

<ul class="summary-list"><li>Vaccine stocks have tumbled since Trump appointed vaccine skeptic Robert F. Kennedy Jr. to health secretary.</li><li>Vaccine-makers Moderna, Pfizer, and GSK saw sharp losses.</li></ul>It's been a tough day for health stocks since Donald Trump announced his appointment of <a target="_blank" href="https://www.businessinsider.com/trump-robert-f-kennedy-jr-rfk-department-health-human-services-2024-11">Robert F. Kennedy Jr.</a> — a staunch vaccine skeptic — as health secretary.The news, which came late in the day on Thursday, sent the shares of vaccine-makers sharply lower on Friday, with <a target="_blank" class="" href="https://markets.businessinsider.com/stocks/mrna-stock">Moderna</a> leading the losses, falling as much as 10%. <a target="_blank" class="" href="https://markets.businessinsider.com/stocks/pfe-stock">Pfizer</a> and <a target="_blank" class="" href="https://markets.businessinsider.com/stocks/nvax-stock">Novavax</a> both dropped 6% at intraday lows, while <a target="_blank" class="" href="https://markets.businessinsider.com/stocks/gsk-stock">GSK</a> lost 5%.But the selling wasn't contained to just vaccine names. It spread into US-exposed European healthcare stocks, such as Novo Nordisk and Roche, which were down 5% and 3% at intraday lows, respectively.The losses extend a days-long skid for the sector after the election results last week saw investors boost bets that Kennedy — a key Trump ally — would notch a cabinet role.Since Election Day, Moderna has fallen more than 30%, while Pfizer has slid 11%. Those losses have stood in contrast to the rally enjoyed by the rest of the market, which has <a target="_blank" class="" href="https://markets.businessinsider.com/news/stocks/trump-election-win-stock-market-today-record-high-sp500-dow-2024-11">rallied</a> on the hopes that Trump's lighter regulatory stance and corporate tax cuts could boost corporate earnings.<a target="_blank" href="https://www.businessinsider.com/robert-f-kennedy-jr-views-vaccines-autism-testing-debunked-2023-7">Kennedy</a> has long railed against vaccines, once calling those that protect against Covid-19 a "crime against humanity." He has treaded more carefully in recent weeks, though, and has said he wouldn't outright ban vaccines."If vaccines are working for somebody, I'm not going to take that away. People ought to have choice," he told <a target="_blank" href="https://www.nbcnews.com/politics/2024-election/trump-win-rfk-jr-says-wont-take-away-anybodys-vaccines-rcna178955">NBC</a> after Trump's election.Since Trump's election win, several analysts have downgraded their outlooks on vaccine stocks amid the rising uncertainty in the industry. Bank of America analysts lowered their price target on Moderna last week, from $110 to $90, partially citing uncertainty after Trump's election win, while Deutsche Bank analyst Emmanuel Papadakis cut his rating on GSK to a hold after Kennedy's appointment."We consider vaccines to be amongst the greatest scientific achievements to impact public health: unfortunately this view is not shared by the nominee," Papadakis wrote in a client note <a target="_blank" class="" href="https://www.bloomberg.com/news/articles/2024-11-15/health-stocks-slide-as-trump-picks-vaccine-skeptic-kennedy">seen by Bloomberg</a>.Formerly an environmental justice lawyer, Kennedy pivoted to running an anti-vaccine charity in recent years, and ran for president as an independent candidate in this election cycle. He dropped out to <a target="_blank" href="https://www.businessinsider.com/rfk-jr-drops-out-presidential-race-2024-8">endorse Trump</a> in August, which some sources reported was a bid to <a target="_blank" href="https://www.businessinsider.com/rfk-wanted-white-house-job-exchange-for-endorsing-trump-report-2024-7">secure a position</a> in the administration.In his role as <a target="_blank" href="https://www.businessinsider.com/how-rfk-jr-plans-to-make-america-healthy-again-2024-11">health secretary</a>, Kennedy will have a top role in health policy in the US, but likely won't be able to actually control which vaccines children are required to get for school. That will remain up to individual states, but he could change vaccine requirements for federal employees or the US military.That's if the Senate confirms his appointment, which some have said could be a close vote considering mixed reactions among policymakers so far.Kennedy has also promoted removing fluoride from water supplies and overhauling federal food regulations, and has supported products like raw milk, which the Food and Drug Administration warns against.He's also floated hopes to cut highly processed food from school lunches, which was a priority under the Obama administration.

Health stocks are tumbling after Trump's appointment of vaccine skeptic RFK Jr.

<ul class="summary-list"><li>Novo Nordisk's Saxenda helped children reduce their BMI by 5.8% in a 56-week trial.</li><li>There are no approved obesity medications for children but Saxenda is approved for teens and adults.</li></ul><a target="_blank" class="" href="https://www.businessinsider.com/novo-nordisk-cut-prices-usa-obesity-drug-wegovy-double-demand-2024-5">Danish drugmaker Novo Nordisk's</a> weight loss drug Saxenda has helped children aged six to 11 <a target="_blank" class="" href="https://www.businessinsider.com/weight-loss-glp-1-drugs-ozempic-wegovy-mounjaro-effects-future-2023-12">reduce their body mass index</a>, according to trial results released on Tuesday.The results showed that the children receiving daily injections of Saxenda were able to cut their BMI by 5.8% on average in the 56-week trial — and by 7.4% on average compared with the placebo group. BMI is a measure of fitness based on height and weight, though it's <a target="_blank" class="" href="https://www.businessinsider.com/bmi-is-bogus-best-way-to-tell-if-youre-a-healthy-weight-2016-9">widely seen as</a> an inaccurate predictor of health.There are<a target="_blank" class="" href="https://www.businessinsider.com/weight-loss-drugs-for-kids-6-years-old-mounjaro-trial-2023-10"> no FDA-approved</a> medications for children with obesity. The agency approved Saxenda, which has the chemical name liraglutide, for teenagers in 2020 and for adults in 2014. Novo will seek FDA approval for the drug for younger children, the company's head of development told the <a target="_blank" class="" href="https://www.ft.com/content/83bfafb7-72a4-455f-8def-0caa959def3d">Financial Times</a>."To date, children have had virtually no options for treating obesity. They have been told to 'try harder' with diet and exercise," said lead researcher Claudia Fox at a meeting in Madrid, where the results of the study of 82 children were presented.The medication can allow children with obesity to live healthier and more productive lives, she said.Novo Nordisk's American rival, Eli Lilly, <a target="_blank" class="" href="https://www.businessinsider.com/weight-loss-drugs-for-kids-6-years-old-mounjaro-trial-2023-10">has also been testing </a><a target="_blank" class="" href="https://www.businessinsider.com/parents-are-putting-their-kids-on-weight-loss-drugs-2023-10">obesity-beating drugs for children </a>as young as six. Novo Nordisk is the drugmaker behind the blockbuster medications Ozempic and Wegovy, while Eli Lilly produces Mounjaro and Zepbound.Wegovy and similar <a target="_blank" rel="" href="https://www.businessinsider.com/tiktok-cracks-down-on-ozempic-content-2024-4">drugs for weight loss</a> have become a huge business. The <a target="_blank" rel="" href="https://stacks.cdc.gov/view/cdc/106273">US adult obesity rate</a> was about 40% from 2017 to 2020, and <a target="_blank" href="https://www.goldmansachs.com/intelligence/pages/anti-obesity-drug-market.html">Goldman Sachs</a> researchers estimated last year that the drugs could be prescribed to 15 million Americans by 2030. The bank's researchers said the anti-obesity drug market could grow to <a target="_blank" rel=" nofollow" href="https://www.goldmansachs.com/intelligence/pages/anti-obesity-drug-market.html">$100 billion</a> by that time.The drugs' success has made Novo Nordisk the most valuable company in Europe. Its stock is up over 25% year-to-date.<h2 id="b3771b30-588f-4b4d-9231-81903e6cdd49">Childhood obesity</h2>An FDA approval on weight loss drugs for children could open up a new market for Novo Nordisk.According to the Centers for Disease Control, <a target="_blank" href="https://www.cdc.gov/obesity/php/data-research/childhood-obesity-facts.html#:~:text=Expand%20All-,Age,%25%20among%20adolescents%2012%E2%80%9319.">one in five children</a> and adolescents in the US have obesity, and the <a target="_blank" href="https://datacenter.aecf.org/data/tables/101-child-population-by-age-group#detailed/1/any/false/2545,1095,2048,574,1729,37,871,870,573,869/62,63,64,6,4693/419,420">number of children</a> ages six to 11 with obesity is about 6 million.Novo's pricing for Ozempic and Wegovy has come under recent political scrutiny. In June, US Sen. Bernie Sanders announced that Novo Nordisk CEO Lars Jørgensen would testify before the committee on September 24 at a hearing focusing on the prices that Novo Nordisk charges Americans for their drugs, Ozempic and Wegovy.Sanders has <a target="_blank" class="" href="https://www.sanders.senate.gov/wp-content/uploads/Letter-from-Sen.-Bernard-Sanders-to-Novo-Nordisk.pdf">investigated</a> the prices, saying that they are higher in the US than in other countries.The highly-coveted drugs are being <a target="_blank" rel="" href="https://www.businessinsider.com/ozempic-celebrities-denied-semaglutide-wegovy-weight-loss-drugs-khloe-kardashian-2023-3">used by celebrities,</a> including Oprah Winfrey, <a target="_blank" rel="" href="https://www.businessinsider.com/elon-musk-weight-loss-drug-wegovy-semaglutide-fit-ripped-healthy-2022-10">Elon Musk</a>, and Charles Barkley, and by <a target="_blank" class="" href="https://www.businessinsider.com/ozempic-is-killing-keto-diet-report-suggests-2024-7">non-celebrities </a>alike.

The next big market for weight-loss drugs: children 

<ul class="summary-list"><li>A federal judge said Mark Zuckerberg is not personally liable in over two dozen lawsuits.</li><li>The lawsuits say Zuckerberg's platforms are addictive to children.</li></ul>A federal judge said <a target="_blank" href="https://www.businessinsider.com/ufc-dana-white-mark-zuckerberg-ai-ranking-system-2024-10">Meta CEO Mark Zuckerberg</a> is not personally liable in over two dozen lawsuits accusing his company of causing social media addiction in children.US District Judge Yvonne Gonzalez Rogers of California shared the decision in a 10-page court filing on Thursday. Plaintiffs said that Meta knew <a target="_blank" href="https://www.businessinsider.com/instagram-adam-mosseri-what-working-for-mark-zuckerberg-is-like-2024-6">Instagram</a> and <a target="_blank" href="https://www.businessinsider.com/facebook-gen-z-young-adults-meta-plan-mark-zuckerberg-2024-6">Facebook</a> posed health risks to its users, especially children.The plaintiffs — which include parents and school districts — say Meta did not disclose the risks associated with the social media platforms, concealed them through "misleading talking points," and prevented users from learning about them.The plaintiffs also say Zuckerberg "directed, participated in, knew of, and in fact, served as the guiding spirit behind Meta's tortious concealment and omissions," according to the court filing.However, the judge said in Thursday's court filing that the plaintiffs had insufficient evidence that Zuckerberg personally directed the suppression of information about the dangers of social media."While possible that discovery may reveal a more active participation and direction by Zuckerberg in Meta's alleged fraudulent concealment, the allegations before the Court are insufficient to meet the standard for corporate-officer liability in the thirteen at-issue jurisdictions," the filing said.The court's ruling comes as world leaders crack down on some social media companies over claims that they are addictive to children and teens. In October, attorneys general from 14 different states <a target="_blank" href="https://www.businessinsider.com/ny-ag-letitia-james-stealth-trump-fraud-tiktok-2024-10">filed lawsuits against TikTok,</a> saying that the app is addictive and profits from damaging the mental health of children.Legal experts previously told Business Insider that the sweeping lawsuits against TikTok <a target="_blank" class="" href="https://www.businessinsider.com/tiktok-lawsuits-mirror-tobacco-purdue-pharma-2024-10">mirror legal strategies</a> used by the US government to crack down on the opioid and tobacco industries.In Australia, Prime Minister Anthony Albanese this week announced plans to introduce a law banning children under 16 from having social media accounts. Meta's head of safety, Antigone Davis, told the Associated Press that the company would respect any age limitations the Australian government wants to introduce.Representatives for Meta declined to comment on the California judge's ruling, and legal representatives for Zuckerberg did not respond to a request for comment from Business Insider.Previn Warren, a representative for the plaintiffs at Motley Rice LLC, told Business Insider that its lawsuit against Meta is still ongoing."Whether Mark Zuckerberg is held accountable in his personal capacity or not, our lawsuit against Meta, the company he has led for 20 years, is moving forward," the statement said. "We will not stop until the hundreds of families and school districts we represent have their day in court. We are moving forward with discovery to uncover the truth about how Big Tech has knowingly prioritized profits over the safety of our children."There are dozens of plaintiffs involved in the ongoing legal procedures. Other defendants listed in the lawsuits included Snap, ByteDance, and Google.In an amended complaint filed in December 2023, the plaintiffs said they have "suffered various personal injuries because of their use of Defendants' products.""These harms include pain, suffering, disability, impairment, disfigurement, death, an increased risk of injury and other serious illnesses, loss of enjoyment of life, loss of society, aggravation or activation of preexisting conditions, scarring, inconvenience, incurred costs for medical care and treatment, loss of wages and wage-earning capacity, and other economic and non-economic damages," the complaint read."These losses are often permanent and continuing in nature," the complaint reads.

Mark Zuckerberg isn't personally liable for any harm caused to children by Facebook and Instagram, judge says

<ul class="summary-list"><li>Rob Archer is a psychologist and father of two based in London.</li><li>He doesn't plan on giving his children smartphones until they leave home.</li></ul>This as-told-to essay is based on a transcribed conversation with Rob Archer, a psychologist and father of two. The following has been edited for length and clarity.As a psychologist who works in the areas of mental health and mental performance, I regularly hear horror stories about how <a target="_blank" class="" href="https://www.businessinsider.com/smartphones-ban-gen-z-school-12-hour-day-social-media-2024-7">technology is affecting children and teenagers.</a>I have two children, one 9-year-old and one 7-year-old, and I'm not planning to give them smartphones until they leave home. I worry about three main things when it comes to children using smartphones. Number one is addiction. The second issue is the opportunity cost. If the average child spends four to five hours of their day on a screen, that comes at the expense of other behaviors. Many teenagers have less sleep than they need because they're doom-scrolling, for example.The third issue is the content itself; I worry about things like violent porn and sextortion.We have no idea who our children are speaking to online. It feels like the Wild West, and there's very little you can do about that as a parent. You can try things like parental controls, but you're fighting a battle that you'll probably lose.My kids won't have smartphones unless there's a massive change in the technology. I don't want to expose them to any kind of addictive screen.I don't judge parents who already have given their children smartphones.However, the data about the impact of this technology has changed over the last five or six years, and we know much more about how it affects our children.In a way, I'm fortunate because of my kids' ages — this new generation of parents has an advantage because we can make collective decisions based on the data coming through.<h2 id="757b957d-0a14-42a9-af2c-f0cad9f5b79e">Collective action</h2>I recently signed up for the Smartphone Free Childhood Pact, a group of parents who pledge to delay giving their children smartphones.The idea behind the project is that you band together, first by district and then by school, with other parents who feel the same way. I think having a group has made people feel more emboldened and less alone. You realize it's not just you thinking these things.If your child is the only one in a class without a phone while everybody else has one, what can you do as a parent? You can't resist it.If everybody else in the class is using smartphones, your child will feel isolated. It will be almost unbearable for them.It's a collective action problem, but if we get at least five or six children in every classroom smartphone-free, it becomes possible for your child to resist having a phone.<div type="image" title="Headshot of Rob Archer, a psychologist and father of two." height="720" width="487" msid="114981169" hostid="261" sizebytes="9634"></div><h2 id="26574f89-a83c-4822-bef8-d01313c6ebcf">Phone-free schools</h2>In our particular school, we've got almost 100 parents signed up for the pact.I've also spoken to the school's headmistress, and we're working with her to try to change the norms around the assumption that children will use smartphones or have access to them at a young age. She's very much on board with the smartphone-free childhood message.We're trying to shift the norms around assuming that children will get these devices.I also speak to my children about it. Since they were 6 years old, I've been talking to them about the reasons they're not getting a phone. I know it will become more difficult as they age, but at the moment, they're on board.I've explained it's not that I don't want them to have a phone; it's that I do want them to have a childhood, and I'm going to fight every inch to give them the childhood that they need.

You Searched For "children s health" and got 5 results

“iPad kids” are less inclined to interact with their parents and show delays in problem-solving: Study

Ashmita Gupta

Health stocks are tumbling after Trump's appointment of vaccine skeptic RFK Jr.

Kelly Cloonan

The next big market for weight-loss drugs: children

Shubhangi Goel

Mark Zuckerberg isn't personally liable for any harm caused to children by Facebook and Instagram, judge says

Lauren Edmonds,Kenneth Niemey…

I'm a father of 2. I won't give my children smartphones while they live at home.

Beatrice Nolan

Popular Keywords

Buying Guides